pharmaceutical investing Cesca Therapeutics Announces Evaluation Agreement With The University Of North Carolina Lineberger Advanced Cellular Therapeutics Facility for X-Series
Cesca Therapeutics Announces First Evaluation Agreement With a Leading U.S. Academic Research Institution for X-Series Products That Provide Automated, Closed System Cellular Processing
Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017
Tartisan Nickel Corp. Acquires Nickel-Copper Claims, Outlines 2026 Work Program at Turtle Pond, Northwestern Ontario
Charbone Annonce Les Resultats De L'assemblee Generale Annuelle Et Extraordinaire Des Actionnaires Et L'octroi D'attributions D'actions
